ADVANCED PHARMACOLOGY
MIDTERM EXAM QUESTIONS
AND CORRECT ANSWERS
Nurse practitioner prescriptive authority is
regulated by:
a. The National Council of Sate Board of Nursing
b. The State Board of Nursing for each state
c. The U. S. Drug Enforcement Administration
d. The State Board of Pharmacy - ANSWER-b. The
State Board of Nursing for each state
Eight Information needed for the prescription -
ANSWER-1. Date of prescribing;
,2. Name of patient(s);
3. Prescriber's name;
4. Name, strength, and dosage of drug or device;
5. Number of refills, if applicable;
6. Quantity prescribed in weight, volume, or
number of units;
7. An indication of whether generic substitution has
been authorized by the prescriber;
8. Any change or alteration made to the prescription
dispensed on contact with the prescriber must show
a clear audit trail.
Three additional required information for controlled
substances - ANSWER-1. Address of the prescriber
and patient;
2. The prescriber's DEA number;
3 Controlled prescriptions shall also comply with all
requirements of federal and state controlled
substance laws.
,Who oversees the APRN's prescribing of controlled
substances?
a. The pharmaceutical board of the state
b. The federal government (DEA)
c. The practice protocols of the hospital
d. Practice agreements - ANSWER-b. The federal
government (DEA)
The USFDA regulates:
a. Prescribing of drugs by medical doctors and nurse
practitioners
b. The official labeling for all prescription and over-
the-counter drugs
c. Off-label recommendations for prescribing
d. Pharmaceutical educational offering - ANSWER-b.
The official labeling for all prescription and over-the-
counter drugs
, Medication agreements or "Pain Medication
Contracts" are recommended to be used:
a. Universally for all prescribing for chronic pain
b. For patients who have repeated requests for pain
medication
c. When you suspect a patient is exhibiting drug-
seeking behavior
d. For patients with pain associated with malignancy
- ANSWER-a. Universally for all prescribing for
chronic pain
Anaphylactic shock is a:
a. Type I reaction, called immediate hypersensitivity
reaction
b. Type II reaction, called cytotoxic hypersensitivity
reaction
MIDTERM EXAM QUESTIONS
AND CORRECT ANSWERS
Nurse practitioner prescriptive authority is
regulated by:
a. The National Council of Sate Board of Nursing
b. The State Board of Nursing for each state
c. The U. S. Drug Enforcement Administration
d. The State Board of Pharmacy - ANSWER-b. The
State Board of Nursing for each state
Eight Information needed for the prescription -
ANSWER-1. Date of prescribing;
,2. Name of patient(s);
3. Prescriber's name;
4. Name, strength, and dosage of drug or device;
5. Number of refills, if applicable;
6. Quantity prescribed in weight, volume, or
number of units;
7. An indication of whether generic substitution has
been authorized by the prescriber;
8. Any change or alteration made to the prescription
dispensed on contact with the prescriber must show
a clear audit trail.
Three additional required information for controlled
substances - ANSWER-1. Address of the prescriber
and patient;
2. The prescriber's DEA number;
3 Controlled prescriptions shall also comply with all
requirements of federal and state controlled
substance laws.
,Who oversees the APRN's prescribing of controlled
substances?
a. The pharmaceutical board of the state
b. The federal government (DEA)
c. The practice protocols of the hospital
d. Practice agreements - ANSWER-b. The federal
government (DEA)
The USFDA regulates:
a. Prescribing of drugs by medical doctors and nurse
practitioners
b. The official labeling for all prescription and over-
the-counter drugs
c. Off-label recommendations for prescribing
d. Pharmaceutical educational offering - ANSWER-b.
The official labeling for all prescription and over-the-
counter drugs
, Medication agreements or "Pain Medication
Contracts" are recommended to be used:
a. Universally for all prescribing for chronic pain
b. For patients who have repeated requests for pain
medication
c. When you suspect a patient is exhibiting drug-
seeking behavior
d. For patients with pain associated with malignancy
- ANSWER-a. Universally for all prescribing for
chronic pain
Anaphylactic shock is a:
a. Type I reaction, called immediate hypersensitivity
reaction
b. Type II reaction, called cytotoxic hypersensitivity
reaction
